24Supplements Announces Investment Opportunity

24SUPPLEMENTS ANNOUNCES GROUNDBREAKING INVESTMENT OPPORTUNITY TO DISRUPT THE EUROPEAN MEDICINAL CANNABIS MARKET

FOR IMMEDIATE RELEASE –1. Octoeber 2024

1. October 2024 – Switzerland – Following its successful launch as a leading CBD marketplace in Switzerland, 24SUPPLEMENTS is excited to announce an exclusive investment opportunity aimed at transforming the European medicinal cannabis industry. With the development of its cutting-edge B2B Medicinal Cannabis Platform, the company is set to revolutionize wholesale transactions between medicinal cannabis cultivators and pharmaceutical companies across Europe.

An Innovative Solution for a Growing Industry

The European medicinal cannabis market is expanding rapidly due to regulatory changes, such as the recent legalization of cannabis in Germany. 24SUPPLEMENTS is leveraging this momentum to disrupt the market with its innovative B2B platform, designed to connect verified cannabis cultivators with pharmaceutical companies.

The platform creates a closed and compliant ecosystem, ensuring every transaction adheres to the highest standards of GDP, GMP, and GACP compliance. By simplifying and streamlining wholesale transactions, 24SUPPLEMENTS’ platform will enable suppliers and buyers to navigate, filter, and finalize transactions with ease, ensuring quality and efficiency in every deal.

“This platform is a significant step forward for the medicinal cannabis industry. It simplifies complex transactions while ensuring compliance and quality,” said Thomas, Founder of 24SUPPLEMENTS. “We’re excited to build the ‘Amazon’ of medicinal cannabis in Europe, connecting the right players to drive industry growth and innovation.”

Exclusive Investment Opportunity

24SUPPLEMENTS is offering a Series A investment opportunity, seeking to raise up to CHF 5 million in tranches of CHF 500,000. The funds will be allocated to support the company’s ambitious growth targets, including:

• Opening four retail stores in key Swiss cities to strengthen consumer presence.
• Further development of the B2B platform, enhancing its functionality and onboarding new suppliers and buyers.
• Expanding collaborations with leading cannabis brands and increasing brand awareness through participation in international cannabis exhibitions.
• Strengthening the team with legal, regulatory, sales, IT and eCommerce expertise.

Why Invest in 24SUPPLEMENTS?

With the European medicinal cannabis market experiencing a 21.56% compound annual growth rate (CAGR), the timing has never been better to invest in a high-growth, high-margin industry. 24SUPPLEMENTS’ unique position as a market leader in Switzerland and its innovative B2B platform in planning, offers investors an unparalleled opportunity to capitalize on this momentum.

With a 5-8 year investment horizon and an IPO as the preferred exit strategy, 24SUPPLEMENTS invites investors to be part of this groundbreaking venture in an evolving and lucrative market.

About 24SUPPLEMENTS

24SUPPLEMENTS is Switzerland’s premier online marketplace for GMP-certified CBD and cannabis products. Launched in September 2024, the platform has quickly established itself as the go-to destination for high-quality CBD products. Now, with the development of its B2B platform, 24SUPPLEMENTS is set to disrupt the European medicinal cannabis wholesale market.

For more information, visit www.24supplements.com.

Media Contact

Thomas | 24SUPPLEMENTS
Email: press@24supplements.com
Website: www.24supplements.com